Table 2.
Approach | Advantage | Disadvantage |
---|---|---|
Whole exome sequencing combined with mass spectrometry | High throughput Identify post-translational modification | Many false positives |
Neoantigens screening through inventory-shared neoantigens library | Labor and time saving | Depend on the capacity of shared antigen database |
Neoantigen screen via trogocytosis | Identify the neoantigen and TCR simultaneously | Hard to manipulate, especially construct SCT cDNA database and transduce into cancer cells |